HTA

All the posts published.

CADTH Pharmaceutical Reviews Update – July 2019

August 16, 2019
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

Spotlight on the Atlantic Provinces: pCPA Letter of Intent Conversion and Time-to-Listing Analysis

January 24, 2019
-
Market Access News, Publications
-
Posted by MORSE Team
Read More →
Read More →

Significant Developments in Canadian Drugs for Rare Disease Policy

November 14, 2018
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

Patient Support Programs – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

November 1, 2018
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

HTA Panel – CAHR Market Access 201: Flying Blind – Navigating Patient Access through Uncertainty

October 18, 2018
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

CADTH & INESSS Pilot Project: Joint Engagement with Clinical Specialists

September 14, 2018
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

A Comparison of Proposed INESSS and Current CADTH Evaluation Fees

March 6, 2018
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

Cornerstone Research Group and MORSE Consulting form a Strategic Partnership

February 7, 2018
-
Market Access News, What's New
-
Posted by MORSE Team
Read More →
Read More →

Introducing MORSE LINKS – A Comprehensive List of Pharmaceutical Market Access Resources

September 26, 2017
-
Market Access News, What's New
-
Posted by MORSE Team
Read More →
Read More →

Upcoming Market Access Events / Conferences – September 2017

August 30, 2017
-
Market Access News
-
Posted by MORSE Team
Read More →
Read More →

Health Technology Assessment Panel – CAHR Market Access 201: Parallel or Intersecting Paths – Future of Public and Private Reimbursement in Canada

August 10, 2017
-
Publications
-
Posted by MORSE Team
Read More →
Read More →
HTA - Info and details on - Page 2 of 2 - MORSE Consulting Inc.